Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant

This publication has 55 references indexed in Scilit:

• Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4⁺T Cells
  Infection and Immunity, 2007
• Cloning, Characterization, and Serodiagnostic Evaluation ofLeishmania infantumTandem Repeat Proteins
  Infection and Immunity, 2006
• Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis
  Vaccine, 2006
• A Heterologous Prime‐Boost Vaccination Regimen Using ORFF DNA and Recombinant ORFF Protein Confers Protective Immunity against Experimental Visceral Leishmaniasis
  The Journal of Infectious Diseases, 2005
• A role for IgG immune complexes during infection with the intracellular pathogen Leishmania
  The Journal of Experimental Medicine, 2005
• Cloning of S -Adenosyl- l -Methionine:C-24-Δ-Sterol-Methyltransferase (ERG6) from Leishmania donovani and Characterization of mRNAs in Wild-Type and Amphotericin B-Resistant Promastigotes
  Antimicrobial Agents and Chemotherapy, 2004
• Influence of the host and parasite strain in a mouse model of visceral Leishmania infantum infection
  FEMS Immunology & Medical Microbiology, 1998
• Influence of the host and parasite strain in a mouse model of visceralLeishmania infantuminfection
  FEMS Immunology & Medical Microbiology, 1998
• Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3.
  The Journal of Experimental Medicine, 1994
• Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.
  Journal of Clinical Investigation, 1985